    Robert Terifay | Regeneron Pharmaceuticals , Inc. | ZoomInfo.com


Robert J Terifay - South San Francisco, CA | Intelius



























Sign In



We found Robert J Terifay in South San Francisco, CA


Robert J Terifay

                                                                           Intelius found that Robert J Terifay  is  a male between 50 and 60 years old from South San Francisco, CA.  We have connected them to
                17 addresses,
                11 phones,
                and 2 relatives or associates.
         






Get Report Now

Age

Robert J Terifay is in his 50s

Robert Has Lived In

South San Francisco, CA
New York, NY
San Francisco, CA

Robert's Relatives

Marianne Fahey
RJ Terifay







Robert J Terifay



Zodiac SignScorpio



GenderMale



Professional Status
Brand Manager at Regeneron Pharmaceuticals , Inc.



Get Report Now










Want to know more about Robert? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Robert, or use our people search engine to find others.
Get Background Check on Robert J Terifay
Get a Criminal Check on Robert J Terifay
Get a Public Record Report on Robert J Terifay
Get a People Search Report on Robert J Terifay


Robert J Terifay's Contact Information
Known Cities Lived In
Find out where Robert J Terifay has lived as well as Robert J Terifay's phone numbers and email addresses.




Robert J Terifay Has Lived in 8 States
California Address for Robert J Terifay


270 E G**** A** 

South San Francisco, CA


Has Lived In

South San Francisco, CA
New York, NY


Get Full Address Report










Phone Numbers Associated with Robert J Terifay

(650) ***-**** - South San Francisco, CA 
(914) ***-**** - Tarrytown, NY 
(914) ***-**** - Tarrytown, NY 


Get Full Phone Report



Email Addresses Associated with Robert J Terifay

r******y@***.com
r******y@***.com
t*****y@***.com


Get Email Report




Robert J Terifay's Professional Information
Information regarding Robert J Terifay's professional history.  Find out previous places Robert J Terifay has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Robert J Terifay Has Worked at 4 Places
Company: Regeneron Pharmaceuticals , Inc.
               Title: Brand Manager
Company: Regeneron Pharmaceuticals , Inc.
               Title: Senior Vice President-commercial
Robert J Terifay's Experience
Title: Brand Manager
               Company: Regeneron Pharmaceuticals , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 1,000 to less than 5,000
Title: Senior Vice President-commercial
               Company: Regeneron Pharmaceuticals , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 1,000 to less than 5,000
Additional Professional Information on Robert J Terifay

 See Robert J Terifay's LinkedIn Profile



Robert J Terifay's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Robert J Terifay


Robert J Terifay's known Social Networks And Potential Email Matches

Find all of Robert J Terifay's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Robert Terifay
Username Matches

                  RobertTerifay
                  TerifayRobert
                  Robert.Terifay
                  Terifay.Robert
                  Robert_Terifay
                  Terifay_Robert
                  Robert-Terifay
                  Terifay-Robert
                  RTerifay
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
R Terifay







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














Robert J Terifay - White Plains, NY | Intelius



























Sign In



We found Robert J Terifay in White Plains, NY


Robert J Terifay

                                                                           Intelius found that Robert J Terifay  is  a male between 50 and 60 years old from White Plains, NY.  We have connected them to
                17 addresses,
                11 phones,
                and 2 relatives or associates.
         






Get Report Now

Age

Robert J Terifay is in his 50s

Robert Has Lived In

White Plains, NY
San Francisco, CA
South San Francisco, CA

Robert's Relatives

Marianne Fahey
RJ Terifay







Robert J Terifay



Zodiac SignScorpio



GenderMale



Professional Status
Brand Manager at Regeneron Pharmaceuticals , Inc.



Get Report Now










Want to know more about Robert? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Robert, or use our people search engine to find others.
Get Background Check on Robert J Terifay
Get a Criminal Check on Robert J Terifay
Get a Public Record Report on Robert J Terifay
Get a People Search Report on Robert J Terifay


Robert J Terifay's Contact Information
Known Cities Lived In
Find out where Robert J Terifay has lived as well as Robert J Terifay's phone numbers and email addresses.




Robert J Terifay Has Lived in 8 States
New York Address for Robert J Terifay


10 C*** P* 

White Plains, NY


Has Lived In

White Plains, NY
San Francisco, CA


Get Full Address Report










Phone Numbers Associated with Robert J Terifay

(650) ***-**** - South San Francisco, CA 
(914) ***-**** - Tarrytown, NY 
(914) ***-**** - Tarrytown, NY 


Get Full Phone Report



Email Addresses Associated with Robert J Terifay

r******y@***.com
r******y@***.com
t*****y@***.com


Get Email Report




Robert J Terifay's Professional Information
Information regarding Robert J Terifay's professional history.  Find out previous places Robert J Terifay has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Robert J Terifay Has Worked at 4 Places
Company: Regeneron Pharmaceuticals , Inc.
               Title: Brand Manager
Company: Regeneron Pharmaceuticals , Inc.
               Title: Senior Vice President-commercial
Robert J Terifay's Experience
Title: Brand Manager
               Company: Regeneron Pharmaceuticals , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 1,000 to less than 5,000
Title: Senior Vice President-commercial
               Company: Regeneron Pharmaceuticals , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 1,000 to less than 5,000
Additional Professional Information on Robert J Terifay

 See Robert J Terifay's LinkedIn Profile



Robert J Terifay's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Robert J Terifay


Robert J Terifay's known Social Networks And Potential Email Matches

Find all of Robert J Terifay's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Robert Terifay
Username Matches

                  RobertTerifay
                  TerifayRobert
                  Robert.Terifay
                  Terifay.Robert
                  Robert_Terifay
                  Terifay_Robert
                  Robert-Terifay
                  Terifay-Robert
                  RTerifay
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
R Terifay







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.













Robert J. Terifay: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 8:45 PM ET
Biotechnology

Company Overview of Regeneron Pharmaceuticals, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Robert J. Terifay  Executive Vice President of Commercial, Regeneron Pharmaceuticals, Inc.AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.57$6,771,209As of Fiscal Year 2016
Background

		Mr. Robert J. Terifay has been Executive Vice President of Commercial at Regeneron Pharmaceuticals, Inc. since January 2016. Mr. Terifay served as a Senior Vice President of Commercial at Regeneron Pharmaceuticals, Inc. since February 26, 2007 until December 2015. Mr. Terifay served as the President and Chief Operating Officer at Arginox Pharmaceuticals, Inc from January 2006 to October 2006. He has more than 20 years of experience in the life science industry and has ... experience in commercial strategy and positioning new products for market-entry in the pharmaceutical industry. Prior to Arginox Pharmaceuticals, Mr. Terifay served as Senior Vice President of Commercial Development and Strategy at Synta Pharmaceuticals Corp. from April 14, 2005 to December 2005, where he was responsible for overall business strategy and development of the infrastructure for a commercial organization. Mr. Terifay served as Senior Vice President of Oncology Commercial for Millennium Pharmaceuticals Inc. and Vice President of Marketing at COR Therapeutics, Inc., where he created and managed the commercial functions for both oncology and acute cardiovascular products. At COR Therapeutics, Mr. Terifay was responsible for establishment of its commercial presence in the acute care cardiovascular market, taking its first product, INTEGRILIN ® (eptifibatide) Injection, a GP IIb/IIIa inhibitor, to market (Millennium acquired COR). He assumed commercial leadership of the oncology group, where he led the launch of VELCADE ® (bortezomib). Before joining COR Therapeutics and Millennium Pharmaceuticals, he served as Executive Vice President of Klemtner Advertising and also served eight years with G. D. Searle and Company in a variety of sales and marketing leadership positions. Mr. Terifay received a Bachelor of Science degree from the University of Notre Dame and a Master of Management degree from the J.L. Kellogg Graduate School of Business at Northwestern University.Read Full Background




Corporate Headquarters
777 Old Saw Mill River RoadTarrytown, New York 10591United StatesPhone: 914-847-7000Fax: --
Board Members Memberships
				There is no Board Members Memberships data available.
				Education
BS University of Notre DameMaster's Degree J.L. Kellogg School of Management, Northwestern University
Other Affiliations
Synta Pharmaceuticals Corp.University of Notre DameJ.L. Kellogg School of Management, Northwestern UniversityArginox Pharmaceuticals, Inc.


Annual Compensation
Salary$550,700Total Annual Compensation$550,700
Stocks Options
All Other Compensation$20,725Exercisable Options$1,395,267Exercisable Options Value$439,731,301Unexercisable Options$96,500Unexercisable Options Value$1,208,250Total Value of Options$440,939,550Total Number of Options$1,491,767
Total Compensation
Total Annual Cash Compensation$1,067,055Total Short Term Compensation$550,700Other Long Term Compensation$20,725Total Calculated Compensation$6,771,209




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationMichel  Vounatsos CEO & DirectorBiogen Inc.$2.0MJean-Paul  Clozel M.D.Co-Founder & CEOActelion Ltd$4.8MFlemming  Ornskov M.D., MBA, MPHCEO, MD & Executive DirectorShire plc$4.3MMark C. Rohr Chairman, Chief Executive Officer and PresidentCelanese Corporation$1.1MJean-Christophe  Tellier Chief Executive Officer and Executive DirectorUCB SA$2.2MCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Regeneron Pharmaceuticals, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close


























 












Robert J. Terifay, Regeneron Pharmaceuticals, Inc. EVP, Commercial - REDBOOKS








































Brands, Marketers, Agencies. Search Less. Sell More.





/   SIGN IN

GET A FREE TRIAL   
CONTACT US: (800) 908-5395





















Robert J. Terifay
EVP, Commercial, Regeneron Pharmaceuticals, Inc.

EMAIL: 
                      







              Real-time sales trigger feed - generated by REDBOOKS machine learning and natural language processing technology, tracking 800,000+ news sources to aggregate all new executives, job/role changes and news on decision makers, brands and agencies in the media/marketing industry.
              

              This sales feed is for Robert J. Terifay at Regeneron Pharmaceuticals, Inc.. Robert J. Terifay works as EVP, Commercial , acting in a Sales role .  Regeneron Pharmaceuticals, Inc. is a leader in Pharmaceuticals & Health Care Products .
              REDBOOKS tracks personnel changes for advertisers spending over $1 million annually.
              

              For more Sales leads or media/marketing prospecting automation, start a free trial now.
              

Recent Related News


06/27/2017:


Investors Buy Regeneron Pharmaceuticals, Inc. (REGN) on Weakness After Insider Selling

Investors bought shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on weakness during trading hours on Monday following insider selling activity. $176.06 million flowed into the stock on the tick-up and $146.85 million flowed out of the stock on the tick-down, for a money net flow of $29.21 million into the stock. Of all stocks tracked, Regeneron Pharmaceuticals had the 19th highest net in-flow for the day. .....

People In This Article:
Robert J. Terifay
 

06/23/2017:


Stock Traders Purchase Large Volume of Put Options on Regeneron Pharmaceuticals (REGN)

Posted by Brent Sawyer on Jun 23rd, 2017 // No Comments
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) was the recipient of some unusual options trading activity on Friday. Stock traders purchased 1,150 put options on the company. This represents an increase of 496% compared to the average daily volume of 193 put options.
In related news, EVP Robert J. Terifay sold 21,147 shares of the business’s stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $468.19, for a total value of $9,900,813.93. .....

People In This Article:
Robert J. Terifay
 






Learn more about Robert J. Terifay  and 260,000+ key contacts

  Create targeted lead lists

  Gain insider knowledge with advanced machine  learning
  Real-time verified contact info



Enter Work Email:

Please enter email address.
 Please enter valid email address.









             Learn more about Robert J. Terifay and 260,000+ key contacts
            



























First Name *

 Please enter first name.




Last Name *

 Please enter last name.






Company Name *

 Please enter company name.






Email *





Phone *

 Please enter phone number.
 Please enter 10 digits number.





What industry are you in? *  
                (Please select one the categories below)
Please enter value for the industry.




                     Media Sales
                  




                     Production
                  




                     Ad-Tech/Mar-Tech
                  




                     Sponsorship Sales
                  



  Agency New Business
                  



  Other:
                  




What is your role? *
                 
                 (Please select one the categories below)
Please enter value for the role.



  C-Suite
                  



  VP/Manager
                  



  Sales Rep
                  



  Other:
                  














Thank you for registering for a Free REDBOOKS.com Trial!
We are processing your request and will be in touch shortly to get you started!
For Immediate Assistance, please call us at (800) 908-5395 or email us at info@redbooks.com


























Home
Learn More
FREE Trial


Features




AD THINK Events
Thought Leadership Events
Top Advertiser Directory
Top Agency Directory



Add Your Agency
Update Your Agency
Agency Showcase
Advertising Associations
Creative Spotlight
Services and Suppliers


About Us
Blog
Contact Us
Jobs
Terms & Conditions
Privacy Policy





Customer Support
(800) 908-5395
Connect with us




















Copyright © 2017 Red Books LLC. All rights reserved

































Robert J. Terifay of Regeneron Pharmaceuticals Inc Executive Profile

















 












Welcome!















Company News
Company Site
Premium
Log In


 



















Membership
Home
Portfolio
Stocks
Bonds
Funds
ETFs
CEF
Markets
Tools
Real Life Finance
Discuss





Investing Ideas


Fund Analyst Picks
Picks by Category
Fund Pick Performance
Picks & Pans E-Newsletter
Fund Spy Column
Fund Spy Book
Bond Squad
Fund Video Reports
FundInvestor Newsletter
ETF Investing
Fund Family Experts



Fund Reports


All Fund Analyst Reports
Fund Stewardship Reports



Fund Ratings


Highest-Rated Value
Highest-Rated Growth
Highest-Rated Large-Cap
Highest-Rated Mid-Cap
Highest-Rated Small-Cap
Foreign Fund Standouts
Star Rating Performance
Rating Methodology



Fund Performance


Top 1-Month Performers
Top YTD Performers
Top 1-Year Performers
Top 3-Year Performers
Top 5-Year Performers
Fund Category Returns
Biggest Daily NAV Changes
Closed-End Funds
Exchange-Traded Funds
Quarterly Market Outlook



Fund Screeners


Basic Screeners
Fund Screener
Long-Term Winners
Solid Small-Growth Funds
Conservative Bond Funds

Premium Screeners
Premium Fund Screener
Index Funds
Hidden Gems
Lower-Risk Foreign Funds


Video Center
 
 

 



 



Regeneron Pharmaceuticals Inc
 REGN


			Morningstar Rating
		



Add to PortfolioGet E-mail AlertsPrint This PagePDF ReportData QuestionQuoteChartStock AnalysisPerformanceKey RatiosFinancialsValuationInsidersOwnershipFilingsBondsOverviewExecutive CompensationInsider ActivityKey ExecutivesBoard of DirectorsCommittees
 


Key Executives
                > Robert J. Terifay
            
Robert J. Terifay, Executive Vice President, Commercial



Profile
Connections






Biography



    Robert J. Terifay, 57, has been Executive Vice President, Commercial since January 2016. From February 2007 to December 2015, he served as Senior Vice President, Commercial. Prior to joining the Company, Mr. Terifay was employed at several biopharmaceutical companies. From January to October 2006, Mr. Terifay served as President and Chief Operating Officer of Arginox Pharmaceuticals. Prior to his employment at Arginox, Mr. Terifay was Senior Vice President, Business Operations at Synta Pharmaceuticals from March to December 2005. From February 2002 until March 2005, he held various senior commercial and marketing positions at Millennium Pharmaceuticals, Inc., most recently as Senior Vice President, Oncology Commercial. Mr. Terifay was Vice President, Marketing at Cor Therapeutics, Inc. from 1996 until its acquisition by Millennium Pharmaceuticals, Inc. in February 2002. Mr. Terifay was Executive Vice President of Strategic Services at Saatchi & Saatchi, an advertising firm, from 1993 to 1996. From 1985 to 1993, he held various commercial and marketing positions at G.D. Searle & Company. Mr. Terifay received his Master of Management degree in Marketing and Health Service Management from the J.L. Kellogg Graduate School of Management, Northwestern University.
    





Board Membership




Robert J. Terifay is not a member of any boards




 


  







We value your feedback. Let us know what you think.













 


Site Directory
Site Map
Our Products












 



 



 




Corrections
Help
Advertising Opportunities
Licensing Opportunities
Glossary
RSS
Mobile Portfolio
Affiliate
Careers 
 


International Sites:
        	Australia
Canada
China
France
Germany
Hong Kong
Italy
The Netherlands
Norway
Spain
U.K.
Switzerland

 




Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry



Premium Stocks by:
            Name
|
Ticker
|
Star Rating
|
Market Cap
|
Stock Type
|
Sector
|
Industry



Premium Mutual Funds by:
            Star Rating
|
Investment Style
|
Total Assets
|
Category
|
Top Holdings
|
Top Sectors
|
Symbol / Ticker
|
Name



Premium ETFs by:
            Star Rating
|
Category
|
Total Assets
|
Symbol / Ticker
|
Name



Popular Articles by:
            Title
|
Date
|
Author
|
Collection
|
Interest
|
Popularity



Popular Investment Categories by:
            Topic
|
Sector
|
Key Indicators
|
User Interest
|
Market Cap
|
Industry




Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.
        © Copyright  Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. Russell 2000 quote is 10 minutes delayed.
 


 






















Robert J. Terifay - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In




















Robert J. Terifay
EVP Commercial at Regeneron Pharmaceuticals, Inc.


View Full Profile
Are you Robert J. Terifay? Claim your profile


 


Sign up for Equilar Atlas and view Robert J. Terifay's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Robert J. Terifay's  network and community.
												FOLLOW changes in Robert J. Terifay's employment and money-in-motion.
												CONNECT with Robert J. Terifay through your network of contacts.
												








Robert J. Terifay's Executive Work History


Current


EVP Commercial, 
Regeneron Pharmaceuticals, Inc.


Past
To view Robert J. Terifay's complete executive work history, sign up now
Education


														 Master's, 
															Northwestern University


Age
57

 
 


Robert J. Terifay's Biography



Robert J. Terifay, 57, has been Executive Vice President, Commercial since January 2016. From February 2007 to December 2015, he served as Senior Vice President, Commercial. Prior to joining the Company, Mr. Terifay was employed at several biopharmaceutical companies. From January to October 2006, Mr. Terifay served as President and Chief Operating Officer of Arginox Pharmaceuticals. Prior to his employment at Arginox, Mr. Terifay was Senior Vice President, Business Operations at Synta Pharmaceuticals from March to December 2005. From February 2002 until March 2005, he held various senior commercial and marketing positions at Millennium Pharm ...
(Read More)

			Robert J. Terifay, 57, has been Executive Vice President, Commercial since January 2016. From February 2007 to December 2015, he served as Senior Vice President, Commercial. Prior to joining the Company, Mr. Terifay was employed at several biopharmaceutical companies. From January to October 2006, Mr. Terifay served as President and Chief Operating Officer of Arginox Pharmaceuticals. Prior to his employment at Arginox, Mr. Terifay was Senior Vice President, Business Operations at Synta Pharmaceuticals from March to December 2005. From February 2002 until March 2005, he held various senior commercial and marketing positions at Millennium Pharmaceuticals, Inc., most recently as Senior Vice President, Oncology Commercial. Mr. Terifay was Vice President, Marketing at Cor Therapeutics, Inc. from 1996 until its acquisition by Millennium Pharmaceuticals, Inc. in February 2002. Mr. Terifay was Executive Vice President of Strategic Services at Saatchi & Saatchi, an advertising firm, from 1993 to 1996. From 1985 to 1993, he held various commercial and marketing positions at G.D. Searle & Company. Mr. Terifay received his Master of Management degree in Marketing and Health Service Management from the J.L. Kellogg Graduate School of Management, Northwestern University.
		
Source: Regeneron Pharmaceuticals, Inc. on 04/25/2017
		
	

 






Sign up for Equilar Atlas and view Robert J. Terifay's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Robert J. Terifay. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Robert J. Terifay's  network and community.
												FOLLOW changes in Robert J. Terifay's employment and money-in-motion.
												CONNECT with Robert J. Terifay through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Robert J. Terifay


















Robert J. Terifay's Connections (29)





Sign up now to view Robert J. Terifay's 29 connections »









Leonard S. Schleifer
Dir., President and Chief Executive Officer, Regeneron Pharmaceuticals, Inc.









Neil Stahl
Executive Vice President, Research and Development, Regeneron Pharmaceuticals, Inc.









Marc Tessier-Lavigne
Scientific Advisor, Agios Pharmaceuticals, Inc.









N. Anthony Coles
Board Member, McKesson Corporation









Daniel P. Van Plew
Senior Vice President and General Manager, Industrial Operations and Product Supply, Regeneron Pharmaceuticals, Inc.









Joseph L. Goldstein
Board Member, Regeneron Pharmaceuticals, Inc.









Joseph J. LaRosa
Senior Vice President, General Counsel and Secretary, Regeneron Pharmaceuticals, Inc.









Robert A. Ingram
Chairman of the Board, BioCryst Pharmaceuticals, Inc.









George D. Yancopoulos
Dir., President and Chief Scientific Officer, Regeneron Pharmaceuticals, Inc.









Murray A. Goldberg
Board Member, Aerie Pharmaceuticals, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
















REGN Robert J. Terifay Insider Trades for Regeneron Pharmaceuticals Inc.


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Regeneron Pharmaceuticals Inc.

                  NASDAQ: REGN
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Regeneron Pharmaceuticals Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:52 p.m.


REGN

/quotes/zigman/77392/composite


$
508.71




Change

0.00
0.00%

Volume
Volume 22,801
Quotes are delayed by 20 min








/quotes/zigman/77392/composite
Today's close

$
			508.41
		


$
				508.71
			
Change

+0.30
+0.06%





Day low
Day high
$499.04
$513.42










52 week low
52 week high

            $325.35
        

            $543.55
        


















Insider Activity


Individual




Robert J. Terifay



Mr. Robert J. Terifay is Senior Vice President-Commercial at Regeneron Pharmaceuticals, Inc.
Mr. Terifay was previously employed as President & Chief Operating Officer by Juventis, Inc., Senior VP-Commercial Development & Strategy by Synta Pharmaceuticals Corp., Senior Vice President-Oncology Commercial by Millennium Pharmaceuticals, Inc., Vice President-Marketing by COR Therapeutics, Inc., Executive Vice President-Strategic Services by Saatchi & Saatchi North America, Inc., and a Principal by G.D. Searle & Co., Inc.
He received his undergraduate degree from the University of Notre Dame and a graduate degree from Northwestern University.



Transactions


Date
Shares
Transaction
Value





06/16/2017
21,147


 
Disposition at $468.19 per share.


9,900,814


06/15/2017
22,192


 
Derivative/Non-derivative trans. at $468.69 per share.


10,401,169


06/15/2017
5,411


 
Derivative/Non-derivative trans. at $468.69 per share.


2,536,082


06/15/2017
48,750


 
Derivative/Non-derivative trans. at $52.03 per share.


2,536,462


08/06/2015
2,486


 
Disposition at $590.57 per share.


1,468,158


08/06/2015
2,542


 
Disposition at $589.76 per share.


1,499,170


08/06/2015
2,126


 
Disposition at $588.55 per share.


1,251,258


08/06/2015
2,482


 
Disposition at $587.35 per share.


1,457,803


08/06/2015
2,007


 
Disposition at $585.22 per share.


1,174,537


08/06/2015
800


 
Disposition at $593.66 per share.


474,928


08/06/2015
23


 
Disposition at $592.4 per share.


13,626


08/06/2015
957


 
Disposition at $591.75 per share.


566,305


08/05/2015
14,292


 
Derivative/Non-derivative trans. at $588.64 per share.


8,412,843


08/05/2015
1,521


 
Derivative/Non-derivative trans. at $588.64 per share.


895,322


08/05/2015
29,236


 
Derivative/Non-derivative trans. at $30.63 per share.


895,498


08/05/2015
3,264


 
Derivative/Non-derivative trans. at $30.63 per share.


99,976


03/17/2015
1,700


 
Disposition at $453.28 per share.


770,576


03/17/2015
3,200


 
Disposition at $452.61 per share.


1,448,352


03/17/2015
700


 
Disposition at $450.95 per share.


315,665


03/17/2015
2,093


 
Disposition at $450.18 per share.


942,227


03/17/2015
300


 
Disposition at $448.87 per share.


134,661


03/17/2015
2,600


 
Disposition at $448.01 per share.


1,164,826


03/17/2015
400


 
Disposition at $454 per share.


181,600


03/16/2015
11,703


 
Derivative/Non-derivative trans. at $444.46 per share.


5,201,516


03/16/2015
1,679


 
Derivative/Non-derivative trans. at $444.46 per share.


746,249


03/16/2015
24,375


 
Derivative/Non-derivative trans. at $30.63 per share.


746,606


02/24/2015
11,173


 
Disposition at $423.67 per share.


4,733,665


02/23/2015
11,458


 
Derivative/Non-derivative trans. at $427.94 per share.


4,903,337


02/23/2015
1,744


 
Derivative/Non-derivative trans. at $427.94 per share.


746,328


02/23/2015
24,375


 
Derivative/Non-derivative trans. at $30.63 per share.


746,606


11/18/2014
7,278


 
Disposition at $405.85 per share.


2,953,777


11/18/2014
3,252


 
Disposition at $404.75 per share.


1,316,247


11/18/2014
2,150


 
Disposition at $403.86 per share.


868,299


11/18/2014
1,500


 
Disposition at $402.71 per share.


604,065


11/18/2014
400


 
Disposition at $401.42 per share.


160,568


11/18/2014
62


 
Disposition at $400.45 per share.


24,828


11/18/2014
1,800


 
Disposition at $408.62 per share.


735,516


11/18/2014
2,200


 
Disposition at $407.85 per share.


897,270


11/18/2014
3,720


 
Disposition at $406.89 per share.


1,513,631


11/17/2014
23,810


 
Derivative/Non-derivative trans. at $401.75 per share.


9,565,668


11/17/2014
2,578


 
Derivative/Non-derivative trans. at $401.75 per share.


1,035,712


11/17/2014
48,750


 
Derivative/Non-derivative trans. at $21.25 per share.


1,035,937


02/18/2014
2,765


 
Disposition at $333.79 per share.


922,930


02/18/2014
6,603


 
Disposition at $332.75 per share.


2,197,149


02/18/2014
3,497


 
Disposition at $331.66 per share.


1,159,816


02/14/2014
13,104


 
Derivative/Non-derivative trans. at $323.3 per share.


4,236,524


02/14/2014
1,826


 
Derivative/Non-derivative trans. at $323.3 per share.


590,346


02/14/2014
27,795


 
Derivative/Non-derivative trans. at $21.25 per share.


590,643


12/18/2013
4,705


 
Derivative/Non-derivative trans. at $21.25 per share.


99,981


05/08/2013
400


 
Disposition at $262.06 per share.


104,824


05/08/2013
4,437


 
Disposition at $261.44 per share.


1,160,010


05/08/2013
3,394


 
Disposition at $260.86 per share.


885,359


05/07/2013
750


 
Derivative/Non-derivative trans. at $261.67 per share.


196,253


05/07/2013
139


 
Derivative/Non-derivative trans. at $261.67 per share.


36,373


05/07/2013
2,173


 
Derivative/Non-derivative trans. at $16.8 per share.


36,506


05/07/2013
6,857


 
Derivative/Non-derivative trans. at $261.67 per share.


1,794,272


05/07/2013
946


 
Derivative/Non-derivative trans. at $261.67 per share.


247,540


05/07/2013
14,750


 
Derivative/Non-derivative trans. at $16.8 per share.


247,800


12/18/2012
5,952


 
Derivative/Non-derivative trans. at $16.8 per share.


99,993


11/23/2012
2,045


 
Disposition at $175.09 per share.


358,060


11/23/2012
6,700


 
Disposition at $174.33 per share.


1,168,011


11/23/2012
1,000


 
Disposition at $173.9 per share.


173,900


11/21/2012
8,323


 
Derivative/Non-derivative trans. at $173.83 per share.


1,446,788


11/21/2012
1,932


 
Derivative/Non-derivative trans. at $173.83 per share.


335,840


11/21/2012
20,000


 
Derivative/Non-derivative trans. at $16.8 per share.


336,000


07/30/2012
2,334


 
Disposition at $137.58 per share.


321,112


07/30/2012
6,600


 
Disposition at $136.26 per share.


899,316


07/30/2012
14,833


 
Disposition at $135.49 per share.


2,009,724


07/30/2012
67


 
Disposition at $134.99 per share.


9,045


07/27/2012
4,839


 
Derivative/Non-derivative trans. at $137.39 per share.


664,831


07/27/2012
1,994


 
Derivative/Non-derivative trans. at $137.39 per share.


273,956


07/27/2012
12,500


 
Derivative/Non-derivative trans. at $21.92 per share.


274,000


07/27/2012
9,856


 
Derivative/Non-derivative trans. at $137.39 per share.


1,354,116


07/27/2012
2,980


 
Derivative/Non-derivative trans. at $137.39 per share.


409,423


07/27/2012
24,375


 
Derivative/Non-derivative trans. at $16.8 per share.


409,500


07/27/2012
5,661


 
Derivative/Non-derivative trans. at $137.39 per share.


777,765


07/27/2012
1,711


 
Derivative/Non-derivative trans. at $137.39 per share.


235,075


07/27/2012
14,000


 
Derivative/Non-derivative trans. at $16.8 per share.


235,200





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. P. Roy Vagelos 
Chairman




Dr. Leonard S. Schleifer 
President, Chief Executive Officer & Director




Mr. Robert E. Landry 
Chief Financial Officer & Senior VP-Finance




Dr. George Damis Yancopoulos 
Director & Chief Scientific Officer




Dr. Peter  Powchik 
Senior Vice President-Clinical Development




Dr. Neil  Stahl 
Executive VP-Research & Development




Ms. Beth F. Levine 
Senior Vice President & Chief Compliance Officer




Dr. Jay S. Markowitz 
Senior Vice President-Portfolio Management




Mr. Robert J. Terifay 
Senior Vice President-Commercial




Dr. Janet  van Adelsberg 
Senior Director-Immunology & Inflammation




Dr. Alan  Shuldiner 
Vice President-Translational Genetics




Mr. Daniel P. Van Plew 
SVP, GM-Industrial Operations & Product Supply




Dr. N. Anthony Coles 
Director




Dr. Huda Y. Zoghbi 
Director




Dr. Bonnie L. Bassler 
Director




Mr. Christopher  Fenimore 
Chief Accounting Officer, VP & Controller




Mr. Potoula  Gjidija 
Head-Media Contacts




Ms. Hala  Mirza 
Head-Corporate Communications




Dr. Manisha A.  Narasimhan 
Investor Relations Contact




Dr. Michael S. Aberman 
Senior VP-Strategy & Investor Relations




Ms. Sally A. Paull 
Senior Vice President-Human Resources




Mr. Joseph J. LaRosa 
Secretary, Senior Vice President & General Counsel




Dr. Ned  Braunstein 
Senior Vice President-Regulatory Affairs




Dr. Marc  Tessier-Lavigne 
Independent Director




Ms. Christine A. Poon 
Independent Director




Mr. Arthur Frederick Ryan 
Independent Director




Mr. George L. Sing 
Independent Director




Dr. Joseph L. Goldstein 
Independent Director




Mr. Charles A. Baker 
Independent Director




Dr. Michael S. Brown 
Independent Class I Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




8:45 PM EDT
July 28, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
7:48pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
6:09pThis basic balanced index fund is beating the hedge fund averages
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































